Federico Grossi - 01 Feb 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol
APLS
Transactions as of
01 Feb 2022
Net transactions value
-$15,218
Form type
4
Filing time
02 Feb 2022, 15:50:36 UTC
Previous filing
01 Feb 2022
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $15,218 -375 -0.36% $40.58 103,566 01 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.